Valneva reports FDA Fast Track Designation for shigella vaccine candidate
PremiumThe FlyValneva reports FDA Fast Track Designation for shigella vaccine candidate
28d ago
Valneva price target lowered to $20 from $23 at H.C. Wainwright
Premium
The Fly
Valneva price target lowered to $20 from $23 at H.C. Wainwright
1M ago
Valneva Outlines Future Growth and Vaccine Pipeline
Premium
Company Announcements
Valneva Outlines Future Growth and Vaccine Pipeline
1M ago
H.C. Wainwright positive on second booster results for VLA15
PremiumThe FlyH.C. Wainwright positive on second booster results for VLA15
2M ago
Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
Premium
The Fly
Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
2M ago
Valneva Advances Lyme Disease Vaccine Candidate
Premium
Company Announcements
Valneva Advances Lyme Disease Vaccine Candidate
2M ago
Valneava and Pfizer Nearing Lyme Vaccine Milestone
PremiumCompany AnnouncementsValneava and Pfizer Nearing Lyme Vaccine Milestone
4M ago
Pfizer, Valneva announce vaccination series completion in VALOR trial
Premium
The Fly
Pfizer, Valneva announce vaccination series completion in VALOR trial
4M ago
Valneva’s Chikungunya Vaccine Wins European Approval
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Wins European Approval
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100